M11.019
Hydroxyapatite deposition disease, unspecified shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite deposition disease (HADD) is a condition characterized by the accumulation of tiny calcium phosphate crystals, known as hydroxyapatite, within the soft tissues of the shoulder. This deposition can lead to inflammation, pain, and reduced mobility in the affected shoulder. The ICD-10 code M11.019 specifically refers to an unspecified shoulder involvement in this condition, indicating that the precise shoulder (right or left) may not be specified.
Causes & Symptoms
Clinical Causes: Degenerative changes in shoulder tendons or bursae Repetitive shoulder movements and overuse Age-related mineralization processes Trauma or shoulder injuries Genetic predisposition to abnormal calcium deposition Underlying metabolic conditions, such as gout or hypercalcemia
Key Symptoms: Localized shoulder pain, which may worsen with movement Swelling and tenderness around the shoulder joint Limited range of motion and stiffness Possible redness and warmth over the affected area Pain that can sometimes radiate down the arm Occasional crepitus or a grating sensation during shoulder movement
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hydroxyapatite deposition disease is primarily based on clinical examination and imaging studies. Healthcare providers may utilize the following methods:
Treatment Protocols: Management of hydroxyapatite deposition disease aims to reduce pain, inflammation, and restore shoulder function. Common treatments include:
Clinical Advice & FAQs
Billing Guidance
Is M11.019 a billable ICD-10 code?
Yes, M11.019 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.019?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, unspecified shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference